ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.79
1.20%
US Tech 100
18,147.20
4.75%
S&P 500
5,287.76
2.51%
US Dollar vs CAD
1.38128
-0.26%
Bitcoin
93,764.54
0.35%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Panbela Therapeutics Inc (PK) (PBLA)

  7. Panbela Therapeutics Inc (PK) (PBLA) News

PBLA

Panbela Therapeutics (PK) (PBLA)

Panbela Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PBLA
DateTimeSourceHeadlineSymbolCompany
02/18/20253:32PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (PK)
02/04/20253:02PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (PK)
01/22/20253:02PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (PK)
01/10/20253:50PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:PBLAPanbela Therapeutics Inc (PK)
11/19/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:05PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:04PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:03PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:02PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20244:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20243:59PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/18/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:15AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:12AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:12AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:09AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:06AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/15/20245:03AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/14/20243:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PBLAPanbela Therapeutics Inc (PK)
11/14/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20246:40PMEdgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipUSOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20246:38PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:27AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:25AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:25AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:24AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
10/29/20248:24AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:PBLA

Your Recent History

NEO
TIF
Ninepoint Target Income
LSE
XS5G
Xs&p 500 Sw 7c�
GEMN
IMXUSD
Immutable X
ASX
OEC
Orbital
LSE
TSL3
3x Tesla
COIN
MNRRBTC
Mooner Token
TG
PSFE
Invesco Markets II
BIBX
CHSUSDT
Chaos Coin
TSX
ZWS
BMO US High Dividend Cov...
COIN
NXNNETH
Nexen
USOTC
PALAF
Paladin Energy (QX)
TG
1VPA
Vipshop
LSE
RTWP
Lg Rus2000 Qual
ASX
NOL
NobleOak Life
LSE
0IFA
Ecolab
COIN
GCXXUSD
GermanCoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads